1ABBV:BIT
AbbVie Common Stock
€230,10
arrow_downward
-0,60%(-1,40) 1D
2 ຕ.ລ., 17 ໂມງ 26 ນາທີ 00 ວິນາທີ GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1ABBV...
Open
€232,20
High
€232,20
Low
€230,10
Mkt. cap
488,55 ຕື້
Avg. vol.
38,00
Volume
26,00
52-wk high
€234,90
52-wk low
€168,00
No. of employees
57 ພັນ
Open
€232,20
High
€232,20
Low
€230,10
Mkt. cap
488,55 ຕື້
Avg. vol.
38,00
Volume
26,00
52-wk high
€234,90
52-wk low
€168,00
No. of employees
57 ພັນ
News stories
From web sources and news partners
AD HOC NEWS
·
9 ຊົ່ວໂມງກ່ອນ
AbbVie stock trades 0.90 percent above its Xetra close of EUR 244.40 in weekend trading
Yahoo! Finance Canada
·
10 ຊົ່ວໂມງກ່ອນ
What Does AbbVie (ABBV) Winning Two FDA Breakthrough Tags Mean For Its Oncology Pipeline?
MarketWatch
·
21 ຊົ່ວໂມງກ່ອນ
AbbVie Inc. stock underperforms Friday when compared to competitors despite daily gains
Traders Union
·
1 ມື້ກ່ອນ
Why is AbbVie stock up 1.8% today?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 ພັນ
Founded10 ມ.ສ. 2012
HeadquartersNorth Chicago, ອິລິນອຍ, ສະຫະລັດ
SectorBiotechnology
Websiteabbvie.com